METABOLIC FOLLOW-UP AT ONE YEAR AND BEYOND OF WOMEN WITH GESTATIONAL DIABETES TREATED WITH INSULIN AND/OR ORAL HYPOGLYCAEMIC AGENTS: STUDY PROTOCOL FOR THE IDENTIFICATION OF A CORE OUTCOMES SET USING A DELPHI SURVEY

Abstract Background Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours.Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagno

It is well documented that non-Anglophone scholars face enormous pressures to publish in peer-reviewed English-medium journals both for their own advancement and for institutional prestige.Yet many of them receive Diabetes Care little support and face big challenges.Scholars’ perceptions of these challenges often differ from those of applied

The asymmetric unit of the Candles title compound, C14H8N2O8·2C3H7NO or L·2DMF (DMF = N,N-dimethylformamide), contains one half of the centrosymmetric molecule L and one solvent molecule, which is disordered between two orientations in a 0.555 (4):0.445 (4) ratio.Intermolecular O—H.O hydrogen bonds li

A simple optimization strategy for the computation of 3D finite-differencing kernels on many-cores architectures is proposed.The 3D finite-differencing computation is split direction-by-direction and exploits two level of parallelism: in-core vectorization and multi-threads shared-memory Face Skin Oil parallelization.The main application of this me